OVDs in Modern Ophthalmic Surgery: Viscoelastic Selection Guide

OVDs in Modern Ophthalmic Surgery: Viscoelastic Selection Guide

No product in the cataract tray is used in every case, costs so little relative to its consequences, and receives so little structured thought as the viscoelastic. A poor OVD choice rarely ruins a day — but it quietly raises endothelial cell loss, IOP-spike rates, and capsulorhexis difficulty across thousands of cases. A deliberate OVD strategy, matched to case type and technique, does the opposite.

This guide reviews the rheology that actually matters at the syringe, the evidence behind the major OVD classes, and a selection framework you can standardise across your theatre.

What an OVD Must Do

Ophthalmic viscosurgical devices perform four mechanical jobs in anterior segment surgery:

• Create and maintain space — deepening the chamber and stabilising the capsular bag for capsulorhexis and IOL implantation.
• Protect tissue — coating the corneal endothelium and iris against ultrasound energy, instrument contact, and nuclear fragments.
• Displace and restrain — flattening the anterior lens capsule to control the rhexis tear, tamponading vitreous after a capsule break, and managing floppy irises.
• Then leave — complete removal at case end to avoid retained-viscoelastic IOP spikes.

No single formulation optimises all four. That tension — space maintenance versus endothelial coating versus ease of removal — is the entire subject of OVD selection, and it maps directly onto rheology.

Rheology in Three Parameters

You do not need a materials degree to choose an OVD; you need three parameters and what they mean in the eye:

1. Viscosity at zero shear rate. Determines how well the agent holds space when nothing is moving — chamber depth during rhexis, bag inflation before IOL insertion. High zero-shear viscosity = strong space maintenance.
2. Pseudoplasticity (shear-thinning). Determines how easily the agent moves when something pushes it — injectability through a 27-gauge cannula, displacement by an advancing IOL. Highly pseudoplastic agents are thick at rest yet flow readily under pressure.
3. Cohesion versus dispersion. The practical master variable. Cohesive OVDs (high molecular weight, long-chain sodium hyaluronate) stick to themselves: superb space maintenance, easy aspiration as a single mass, but poor coating — they leave the endothelium exposed during phaco. Dispersive OVDs (lower molecular weight hyaluronate, chondroitin sulfate blends, HPMC) spread and coat tissues, staying behind during phaco to protect the endothelium — but they hold space weakly and resist removal, lingering in the angle where they can obstruct outflow.

The Evidence Base

The classic literature remains the best guide. Arshinoff's work established both the dispersive–cohesive taxonomy and the soft-shell technique (Journal of Cataract & Refractive Surgery, 1999), in which a low-viscosity dispersive layer is placed against the endothelium and a cohesive agent beneath it pressurises and holds the chamber — combining coating protection with space maintenance, then allowing staged removal.

Comparative clinical studies have quantified the endothelial stakes. Lane and colleagues (Ophthalmology, 1991) and subsequent studies showed dispersive agents such as chondroitin sulfate–hyaluronate combinations reduce endothelial cell loss during phacoemulsification relative to cohesive agents alone. On the other side of the ledger, Rainer and colleagues (Journal of Cataract & Refractive Surgery, 2000) documented early postoperative IOP behaviour with higher-viscosity agents, reinforcing the removal imperative: retained OVD is the dominant cause of day-one pressure spikes, and dispersive agents — precisely because they linger — demand the most thorough evacuation.

The evidence-based synthesis used by most high-volume surgeons today:

• Endothelial protection during phaco favours dispersive coating (alone in soft eyes, or as the upper layer of a soft shell).
• Capsulorhexis control and bag inflation favour cohesive space-holding.
• Removal completeness favours cohesive agents — and punishes dispersive retention with pressure spikes.
• Routine soft cataracts in young endothelium tolerate simpler single-agent strategies; dense nuclei, Fuchs' dystrophy, shallow chambers, and complicated cases repay deliberate two-agent strategies.

Matching OVD Class to Case Type

Routine phaco, healthy endothelium

A single mid-cohesive sodium hyaluronate (1.0–1.4%) is adequate for the majority of lists: easy injection, reliable rhexis flattening, fast aspiration. Cost-efficient cohesive OVDs standardised across theatres simplify nursing stock and surgeon behaviour alike.

Dense nucleus, long phaco time, or compromised endothelium

Upgrade endothelial protection. Options: a dispersive OVD placed against the cornea before phaco (replenished as needed), or the full soft-shell combination. In Fuchs' dystrophy this is not refinement — it is cell-count preservation in an eye with no margin.

Shallow chamber, high myope, or positive vitreous pressure

Space maintenance is the binding constraint: choose the highest zero-shear-viscosity cohesive agent available, or consider a viscoadaptive formulation engineered to behave cohesively at rest yet fracture controllably under phaco turbulence. Deep-chamber stability here prevents rhexis run-out more effectively than any change in technique.

Intraoperative floppy iris syndrome and small pupils

High-viscosity cohesive or viscoadaptive agents mechanically restrain the iris margin; viscous tamponade at the wound limits prolapse. Combine with pupil-expansion devices where pharmacology fails.

Capsule rupture and vitreous presentation

A dispersive agent is the tamponade of choice over a posterior capsule break: it resists displacement by vitreous, compartmentalising the anterior segment while you convert to vitrectomy or place a sulcus lens. Cohesive agents herniate and wash out too readily to hold this space.

Trabeculectomy, canal surgery, and anterior segment reconstruction

Space-holding without clogging outflow pathways argues for cohesive agents with complete removal; in glaucoma-combined cases, a retained dispersive layer can produce dangerous early pressure spikes in an optic nerve that cannot tolerate them.

Viscoadaptive OVDs: The Third Class

Between the classic cohesive and dispersive families sits a third engineered category: viscoadaptive agents, most famously ultra-high-viscosity sodium hyaluronate formulations. Their design intent is context-sensitive behaviour — cohesive-like space maintenance at low shear, then controlled fracturing into removable pieces under the turbulence of phaco rather than the cohesive mass's tendency to aspirate away entirely. In practice, viscoadaptives excel where chamber stability is the binding problem: shallow chambers, positive pressure, IFIS, and small-pupil cases. The trade-offs are cost per syringe and a removal profile that still demands diligence — high viscosity in the angle is high viscosity wherever it lands. For theatres that stock three OVDs, the viscoadaptive is the logical third: cohesive or HPMC as default, dispersive for coating and rupture tamponade, viscoadaptive for hostile chambers.

Storage, Handling, and Injectability

OVD performance degrades silently when logistics fail, and the degradation shows up as handling surprises mid-case:

• Temperature discipline. Most sodium hyaluronate OVDs specify refrigerated or controlled room-temperature storage; exceeding labelled conditions alters viscosity and can shorten effective shelf life. HPMC formulations generally tolerate ambient storage better — one reason they dominate outreach work. Follow each product's IFU and monitor theatre refrigerator logs as a quality-system item, not housekeeping.
• Warm-up time. Refrigerated OVD injected cold is dramatically more viscous than at room temperature — the classic cause of "the syringe felt blocked." Standardise a warm-up interval (commonly 20–30 minutes) before scheduled use.
• Cannula and syringe integrity. Bent cannulas, loose Luer fittings, and partially expelled air bubbles all change injection dynamics at the moment of rhexis. Inspect before the case starts.
• Expiry governance. Viscoelastic is a perishable pharmaceutical-grade product. First-expiry-first-out rotation and monthly expiry audits are basic; expired OVD in a rupture kit is a systems failure, not bad luck.

HPMC and the Economics of Scale

Hydroxypropyl methylcellulose occupies a distinct niche: non-animal, non-fermentation origin; excellent coating; moderate space maintenance; and substantially lower cost per case. In high-volume programmes — screening camps, government cataract initiatives, and cost-constrained ASCs across India, Southeast Asia, and Africa — HPMC-based OVDs deliver clinically acceptable performance at a fraction of hyaluronate pricing. The trade-offs are real (slightly lower viscosity, different removal feel, and in some formulations a brief postoperative IOP rise), but for routine nuclei in healthy eyes they are the backbone of volume ophthalmology worldwide.

Removal Technique: Where IOP Spikes Are Won and Lost

Whatever you inject, what you leave behind determines the day-one pressure check. Practical removal discipline:

• Use a bimanual or coaxial irrigation/aspiration pass behind the optic, rocking the IOL gently to release OVD trapped in the retro-lenticular space — the single most common retention site.
• Sweep the angle and capsular fornix, not just the central chamber, especially with dispersive agents.
• Consider a brief low-vacuum polish of the posterior capsule as the final aspiration pass in dense-nucleus cases.
• In glaucoma suspects and high-myopes, check and burp the wound or prescribe prophylactic IOP management per your protocol; see our post-operative drops guide for evidence-based adjuncts.

Beyond Cataract: OVDs Across the Anterior Segment

The selection logic travels. In penetrating keratoplasty, cohesive agents protect donor endothelium and hold the recipient bed; dispersives tamponade open-sky bleeding poorly and are used sparingly. In goniotomy and canal-based MIGS, viscoelastic pressurisation of Schlemm's canal and complete removal from the angle are competing demands — choose cohesive, aspirate obsessively. In anterior chamber IOL or iris-fixated lens work, space maintenance without endothelial contact defines agent choice. And in paediatric cataract, where the capsule is elastic and the rhexis wants to run peripheral, a flattened anterior capsule from a high-viscosity cohesive agent is often the difference between a controlled opening and an extension. One rheology framework, many theatres.

What to Standardise in Your Theatre

1. A default agent for routine cases (cohesive or HPMC, by budget).
2. A defined upgrade pathway for dense nuclei, Fuchs', and shallow chambers (dispersive or soft-shell).
3. A rupture-kit dispersive on every trolley.
4. A written removal protocol with retro-optic aspiration as a mandatory step.
5. Supplier qualification: rheological specifications per lot, endotoxin testing, sterile-fill documentation, and cold-chain or storage compliance.
6. A feedback loop: day-one IOP spike rates and surgeon-reported handling scores reviewed quarterly by agent, so that formulary decisions track your own outcomes rather than habit. Oculentis Medical's CE Marked, CDSCO-licensed OVD range — cohesive, dispersive, and HPMC — is manufactured under ISO 13485 with published rheological specifications; consult each product's IFU.

Frequently Asked Questions

What is the difference between cohesive and dispersive OVDs?

Cohesive OVDs are high-molecular-weight agents that hold space well and are removed easily as a single mass, but coat tissues poorly. Dispersive OVDs spread over and protect the corneal endothelium during phaco, but maintain space weakly and are harder to remove completely, raising postoperative IOP spike risk if retained.

What is the soft-shell technique in cataract surgery?

The soft-shell technique, described by Arshinoff, layers a low-viscosity dispersive OVD against the corneal endothelium and injects a cohesive agent beneath it to deepen the chamber. This combines endothelial coating protection during phaco with cohesive space maintenance, followed by staged removal of both agents.

Which OVD is best for a dense cataract?

For dense nuclei requiring long phaco time, endothelial protection is the priority: use a dispersive OVD coating the endothelium, or a full soft-shell combination of dispersive plus cohesive agents. This reduces ultrasound- and fragment-related endothelial cell loss compared with a cohesive agent alone.

Why do OVDs cause postoperative IOP spikes?

Retained viscoelastic mechanically obstructs trabecular outflow, causing early postoperative pressure elevation — typically peaking within the first 24 hours. Dispersive agents, which linger by design, carry the highest retention risk. Thorough removal, especially aspiration behind the IOL optic, is the primary prevention.

Is HPMC a good viscoelastic for high-volume cataract surgery?

Yes. Hydroxypropyl methylcellulose offers adequate space maintenance and good tissue coating at substantially lower cost than sodium hyaluronate agents, making it the standard OVD in many high-volume and outreach cataract programmes, with the caveat of thorough removal and slightly different handling characteristics.

---

Match your OVD strategy to your case mix. Oculentis Medical manufactures CE Marked, CDSCO-licensed cohesive, dispersive, and HPMC ophthalmic viscosurgical devices in Mumbai under ISO 13485. Request a product sample for rheological evaluation on your own lists, or download IFUs for full specifications. Regulatory status varies by country; always consult the Instructions for Use before use.

---

This article is for educational purposes and is intended for healthcare professionals. It does not constitute medical advice and does not replace the Instructions for Use supplied with each product. Clinical decisions should be based on the surgeon's professional judgement, the individual patient's condition, and the current product IFU. Regulatory status varies by country; please contact Oculentis Medical for information specific to your market.